Dahan Michel - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 13, 2024, Dahan Michel's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (SVP, Chief Operating Officer), and currently has 672,092 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AKBA insiders.
Data Source: SEC.
Dahan Michel - Insider Non-Derivative Transactions of AKBA Common Stock
Dahan Michel - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
May 14, 2024 | Sell -- (Common Stock) | 34840 | 1.26 | 672092 |
Mar 1, 2024 | Sell -- (Common Stock) | 8661 | 1.58 | 706932 |
Feb 28, 2024 | Sell -- (Common Stock) | 10744 | 1.52 | 715593 |
Feb 1, 2024 | Acquisition -- (Common Stock) | 149300 | 0 | 726337 |
May 26, 2023 | Sell -- (Common Stock) | 95478 | 1.22 | 574037 |
May 25, 2023 | Acquisition -- (Common Stock) | 200000 | 0 | 669515 |
May 13, 2023 | Acquisition -- (Common Stock) | 200000 | 0 | 469515 |
Mar 2, 2023 | Sell -- (Common Stock) | 1878 | 0.88 | 269515 |
Mar 2, 2023 | Sell -- (Common Stock) | 10476 | 0.88 | 271393 |
Mar 2, 2023 | Sell -- (Common Stock) | 8058 | 0.88 | 281869 |
Feb 28, 2023 | Sell -- (Common Stock) | 10090 | 0.81 | 289927 |